PHILADELPHIA, PA -- Dec 8, 2008 -- GlaxoSmithKline (NYSE:GSK - News) announced today that the U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, ...
The US Food and Drug Administration approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older. Currently, there are vaccines approved for the ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
GSK plc GSK announced that the FDA expanded Boostrix’s label for immunization during pregnancy to help prevent pertussis (whooping cough) in infants not older than two months. Following the label ...
PHILADELPHIA, PA, May 3, 2005 – GlaxoSmithKline (NYSE: GSK) today announced that its booster vaccine, Boostrix® [Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than two months ...
Portrait of young happy pregnant woman standing by the window Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy ...
WASHINGTON, Nov. 2 (UPI) -- GlaxoSmithKline said Tuesday its booster vaccine candidate, Boostrix, has been found to be effective in preventing pertussis or whooping cough. A phase III clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback